Sort
17,828 grants matching “crispr”
Uncovering the genetically-driven differential susceptibility to chronic obstructive pulmonary disease and pulmonary fibrosis
$781,643Michael H. Cho · Brigham And Women'S Hospital · R01 · FY2023 · HL
Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism
$781,258Alysson R. Muotri · University Of California, San Diego · R01 · FY2025 · MH
Cas9 RNP delivery to immune cells in vivo via molecular targeting
$781,190Ross C Wilson · University Of California Berkeley · UG3 · FY2020 · AI
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes
$780,310Julia Tcw · Boston University Medical Campus · R01 · FY2025 · AG
Targeting proteostatic mechanisms to inhibit LRRK2-mediated neurodegeneration and neuropathology
$780,220Annie E Hiniker · University Of Southern California · R01 · FY2024 · NS
Modeling Alzheimer's disease genetic variants in hiPSC
$779,733Jubao Duan · Endeavor Health Clinical Operations · R01 · FY2019 · AG
Enabling AI-based Mouse Genetic Discovery
$779,707Gary A Peltz · Stanford University · R24 · FY2023 · OD
Mechanism of protein quality control at the endoplasmic reticulum
$779,674Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Safe harbor landing sites as community resource for next-generation transgenesis in zebrafish
$779,657Christian Mosimann · University Of Colorado Denver · R24 · FY2025 · OD
Functional Genomics of Atrial Fibrillation
$779,471Mina Kay Chung · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL
Advancing the development of a novel class of small molecules for treating pan-coronavirus infections
$779,425Shirit Einav · Stanford University · R01 · FY2021 · AI
Development of a nanoparticle-based gene editing technology for neurological applications
$779,310Krystof S Bankiewicz · Ohio State University · UG3 · FY2019 · NS
IL-2:IL-15 : implications for cancer therapy
$779,153Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Gene Transfer Core, NIDCR-DIR
$779,129Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIC · FY2022 · DE
Advancing programmable RNA-targeting tools for research and therapeutics
$778,909Feng Zhang · Broad Institute, Inc. · R01 · FY2022 · HG
Chromatin Structure in Regulation of Mammalian Gene Expression
$778,905Ann Dean · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
FHOD3 Regulation of Autophagy Pathway in Cardiomyopathy
$778,738Gordon S Huggins · Tufts Medical Center · R01 · FY2025 · HL
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
$778,292Benjamin Solomon Freedman · University Of Washington · UH3 · FY2024 · TR
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
$778,292Jonathan Himmelfarb · University Of Washington · UH3 · FY2023 · TR
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems
$778,292Jonathan Himmelfarb · University Of Washington · UH3 · FY2022 · TR
Mechanisms of Post-transcriptional Gene Regulation by PTB and Rbfox Proteins
$778,112Douglas L. Black · University Of California Los Angeles · R35 · FY2021 · GM
Mechanisms of Post-transcriptional Gene Regulation by PTB and Rbfox Proteins
$778,112Douglas L. Black · University Of California Los Angeles · R35 · FY2022 · GM
Mechanisms of Post-transcriptional Gene Regulation by PTB and Rbfox Proteins
$778,112Douglas L. Black · University Of California Los Angeles · R35 · FY2023 · GM
Mechanisms of Post-transcriptional Gene Regulation by PTB and Rbfox Proteins
$778,112Douglas L. Black · University Of California Los Angeles · R35 · FY2024 · GM
Enabling immunotherapy for high-risk Group 3 medulloblastoma via systems immunology
$778,050Hongbo Chi · St. Jude Children'S Research Hospital · U01 · FY2024 · CA